Clinical Trials Directory

Trials / Completed

CompletedNCT03031301

A Study to Assess the Efficacy and Safety of the Vibrant Capsule Administered 5 Times Per Week

A Prospective, Multicenter, Randomized, Double-blind, Sham-controlled Study to Assess the Efficacy and Safety of the Vibrant Capsule Administered 5 Times Per Week

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
182 (actual)
Sponsor
Vibrant Ltd. · Industry
Sex
All
Age
22 Years
Healthy volunteers
Not accepted

Summary

The study is a prospective, adaptive, multicenter, randomized, double-blind, Sham-controlled study, to evaluate the efficacy and safety of the Vibrant Capsule in relieving constipation in subjects with functional constipation. Two arms will be assessed: * Vibrant Capsule administered 5 times per week * Sham Capsule administered 5 times per week

Detailed description

The study is a prospective, adaptive, multicenter, randomized, double-blind, Sham-controlled study, to evaluate the efficacy and safety of the Vibrant Capsule in relieving constipation in subjects with functional constipation. Two arms will be assessed: * Vibrant Capsule administered 5 times per week * Sham Capsule administered 5 times per week Subjects will follow a 2 weeks baseline period and then take the Vibrant Capsule for a treatment period of 8 weeks. Data reporting will be done on an electronic Case Report Form (eCRF) and an eDiary. Subjects will be asked to refrain from taking any medication or supplement to relieve their constipation, during the entire study period. After the 14 days of run-in period, the subjects will return and eligibility will be re-assessed. Subjects will be trained on how to use the base unit and will swallow the first capsule on site the day of baseline visit. They will activate and ingest the rest of the capsules at home by themselves, using the base unit. Subjects will be instructed to complete a simple subject eDiary each day throughout the duration of the study. A final visit will take place at the end of the 8 week treatment period. Subjects will receive phone calls at least once a week and subject compliance will be monitored during the 8 weeks of the study.

Conditions

Interventions

TypeNameDescription
DEVICEVibrant capsuleOne Vibrant capsule will be ingested 5 times per week for 8 weeks of treatment.
DEVICESham capsuleOne Sham capsule will be ingested 5 times per week for 8 weeks of treatment.

Timeline

Start date
2017-02-01
Primary completion
2018-07-30
Completion
2018-07-30
First posted
2017-01-25
Last updated
2024-07-03
Results posted
2024-07-03

Locations

2 sites across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03031301. Inclusion in this directory is not an endorsement.